Case Report
X-Linked Lymphoproliferative Syndrome and Common Variable Immunodeficiency May Not Be Differentiated by SH2D1A and XIAP/BIRC4 Genes Sequence Analysis
Table 1
Laboratory findings of patient.
| | Patient | Normal values for his age |
| | IgG (mg/dL) | 694 | | | IgM (mg/dL) | 84.7 | | | IgA (mg/dL) | 39 | | | WBC/mm3 | 14600 (26% pnl, 70% lym, 4% mono) | 4000–10400 | | Absolute lymphocyte counts/mm3 | 10220 | 1500–5200 | | CD3+ (%-absolute count) | 51–5212 | 55–79/1900–3600 | | CD19+ (%-absolute count) | 37–3781 | 11–31/300–1200 | | CD3+CD4+ (%-absolute count) | 17–1737 | 26–49 / 600–2000 | | CD3+CD8+ (%-absolute count) | 27–2759 | 9–35/300–1300 | | CD19+CD40+ (%-absolute count) | 37–3781 | Expressed on all B lymphocytes | | CD40L+ on activated T cells (%) | 75 | 50 (24 hours after stimulation) | | CD3−CD56+CD16+ (NK) (%-absolute count) | 8–817 | 4–26/90–900 | | CD3−CD56+CD16+ (NKT) (%-absolute count) | 1.8 | >4 | | Anti-nuclear antikor | Negative | Negative | | Direct Coombs | Negative | Negative | | AntiEBV VCA (IgM) | Negative | Negative | | AntiEBV VCA (IgG) | Positive | Negative | | AntiEBV EBNA (IgG) | Positive | Negative | | EBV anti-EA | Negative | Negative | | EBV DNA | Positive (lymph node biopsy) | Negative |
|
|
